Tackling the Challenges in the Manufacturing of Cell-Based Therapies

While cell-based therapies offer huge potential, significant challenges, including GMP manufacturing, scaling-out, and delivery must be addressed and overcome in order to justify and successfully autologous and allogeneic provides to the market.
Susan McKee, Business Development Manager, Angel Biotechnology


Listen to the audio cast here

[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Tackling-the-Challenges-in-the-Manufacturing-of-Cell-Based-Therapies.mp3″]